secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2025-08-04T23:59:59+00:00
Accession:  0001437749-25-024625
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Leanne Kelly resigns from Windtree board; Andrew Kucharchuk appointed as replacement and Audit Committee chair
--------------------------------------------------------------------------------

- Leanne Kelly resigned from Windtree Therapeutics board effective July 29, 2025; she had been Audit Committee chair.
- Andrew Kucharchuk appointed to board effective August 3, 2025, also appointed chair of Audit Committee.
- Kucharchuk is CFO of Cero Therapeutics Holdings and Chain Bridge I; previously CFO of Theralink Technologies.
- No material arrangements, transactions, or compensatory grants disclosed in connection with Kucharchuk's appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774925024625/0001437749-25-024625-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774925024625/wint20250804_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-024625

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer